Cargando…

Cu(II) and Ni(II) Interactions with the Terminally Blocked Hexapeptide Ac-Leu-Ala-His-Tyr-Asn-Lys-amide Model of Histone H2B (80–85)

The N- and C-terminal blocked hexapeptide Ac-Leu-Ala-His-Tyr-Asn-Lys-amide (LAHYNK) representing the 80–85 fragment of histone H2B was synthesized and its interactions with Cu(II) and Ni(II) ions were studied by potentiometric, UV-Vis, CD, EPR, and NMR spectroscopic techniques in solution. Our data...

Descripción completa

Detalles Bibliográficos
Autores principales: Panagiotou, Katerina, Panagopoulou, Maria, Karavelas, Tilemachos, Dokorou, Vassiliki, Hagarman, Andrew, Soffer, Jonathan, Schweitzer-Stenner, Reinhard, Malandrinos, Gerasimos, Hadjiliadis, Nick
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2292837/
https://www.ncbi.nlm.nih.gov/pubmed/18431450
http://dx.doi.org/10.1155/2008/257038
_version_ 1782152530681135104
author Panagiotou, Katerina
Panagopoulou, Maria
Karavelas, Tilemachos
Dokorou, Vassiliki
Hagarman, Andrew
Soffer, Jonathan
Schweitzer-Stenner, Reinhard
Malandrinos, Gerasimos
Hadjiliadis, Nick
author_facet Panagiotou, Katerina
Panagopoulou, Maria
Karavelas, Tilemachos
Dokorou, Vassiliki
Hagarman, Andrew
Soffer, Jonathan
Schweitzer-Stenner, Reinhard
Malandrinos, Gerasimos
Hadjiliadis, Nick
author_sort Panagiotou, Katerina
collection PubMed
description The N- and C-terminal blocked hexapeptide Ac-Leu-Ala-His-Tyr-Asn-Lys-amide (LAHYNK) representing the 80–85 fragment of histone H2B was synthesized and its interactions with Cu(II) and Ni(II) ions were studied by potentiometric, UV-Vis, CD, EPR, and NMR spectroscopic techniques in solution. Our data reveal that the imidazole N(3) nitrogen atom is the primary ligating group for both metal ions. Sequential amide groups deprotonation and subsequent coordination to metal ions indicated an {N(imidazole), 3N(amide)} coordination mode above pH∼9, in all cases. In the case of Cu(II)-peptide system, the almost exclusive formation of the predominant species CuL in neutral media accounting for almost 98% of the total metal ion concentration at pH 7.3 strongly indicates that at physiological pH values the sequence -LAHYNK- of histone H2B provides very efficient binding sites for metal ions. The imidazole pyrrole N(1) ionization (but not coordination) was also detected in species CuH(−4)L present in solution above pH ∼ 11.
format Text
id pubmed-2292837
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-22928372008-04-22 Cu(II) and Ni(II) Interactions with the Terminally Blocked Hexapeptide Ac-Leu-Ala-His-Tyr-Asn-Lys-amide Model of Histone H2B (80–85) Panagiotou, Katerina Panagopoulou, Maria Karavelas, Tilemachos Dokorou, Vassiliki Hagarman, Andrew Soffer, Jonathan Schweitzer-Stenner, Reinhard Malandrinos, Gerasimos Hadjiliadis, Nick Bioinorg Chem Appl Research Article The N- and C-terminal blocked hexapeptide Ac-Leu-Ala-His-Tyr-Asn-Lys-amide (LAHYNK) representing the 80–85 fragment of histone H2B was synthesized and its interactions with Cu(II) and Ni(II) ions were studied by potentiometric, UV-Vis, CD, EPR, and NMR spectroscopic techniques in solution. Our data reveal that the imidazole N(3) nitrogen atom is the primary ligating group for both metal ions. Sequential amide groups deprotonation and subsequent coordination to metal ions indicated an {N(imidazole), 3N(amide)} coordination mode above pH∼9, in all cases. In the case of Cu(II)-peptide system, the almost exclusive formation of the predominant species CuL in neutral media accounting for almost 98% of the total metal ion concentration at pH 7.3 strongly indicates that at physiological pH values the sequence -LAHYNK- of histone H2B provides very efficient binding sites for metal ions. The imidazole pyrrole N(1) ionization (but not coordination) was also detected in species CuH(−4)L present in solution above pH ∼ 11. Hindawi Publishing Corporation 2008 2008-04-13 /pmc/articles/PMC2292837/ /pubmed/18431450 http://dx.doi.org/10.1155/2008/257038 Text en Copyright © 2008 Katerina Panagiotou et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Panagiotou, Katerina
Panagopoulou, Maria
Karavelas, Tilemachos
Dokorou, Vassiliki
Hagarman, Andrew
Soffer, Jonathan
Schweitzer-Stenner, Reinhard
Malandrinos, Gerasimos
Hadjiliadis, Nick
Cu(II) and Ni(II) Interactions with the Terminally Blocked Hexapeptide Ac-Leu-Ala-His-Tyr-Asn-Lys-amide Model of Histone H2B (80–85)
title Cu(II) and Ni(II) Interactions with the Terminally Blocked Hexapeptide Ac-Leu-Ala-His-Tyr-Asn-Lys-amide Model of Histone H2B (80–85)
title_full Cu(II) and Ni(II) Interactions with the Terminally Blocked Hexapeptide Ac-Leu-Ala-His-Tyr-Asn-Lys-amide Model of Histone H2B (80–85)
title_fullStr Cu(II) and Ni(II) Interactions with the Terminally Blocked Hexapeptide Ac-Leu-Ala-His-Tyr-Asn-Lys-amide Model of Histone H2B (80–85)
title_full_unstemmed Cu(II) and Ni(II) Interactions with the Terminally Blocked Hexapeptide Ac-Leu-Ala-His-Tyr-Asn-Lys-amide Model of Histone H2B (80–85)
title_short Cu(II) and Ni(II) Interactions with the Terminally Blocked Hexapeptide Ac-Leu-Ala-His-Tyr-Asn-Lys-amide Model of Histone H2B (80–85)
title_sort cu(ii) and ni(ii) interactions with the terminally blocked hexapeptide ac-leu-ala-his-tyr-asn-lys-amide model of histone h2b (80–85)
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2292837/
https://www.ncbi.nlm.nih.gov/pubmed/18431450
http://dx.doi.org/10.1155/2008/257038
work_keys_str_mv AT panagiotoukaterina cuiiandniiiinteractionswiththeterminallyblockedhexapeptideacleualahistyrasnlysamidemodelofhistoneh2b8085
AT panagopouloumaria cuiiandniiiinteractionswiththeterminallyblockedhexapeptideacleualahistyrasnlysamidemodelofhistoneh2b8085
AT karavelastilemachos cuiiandniiiinteractionswiththeterminallyblockedhexapeptideacleualahistyrasnlysamidemodelofhistoneh2b8085
AT dokorouvassiliki cuiiandniiiinteractionswiththeterminallyblockedhexapeptideacleualahistyrasnlysamidemodelofhistoneh2b8085
AT hagarmanandrew cuiiandniiiinteractionswiththeterminallyblockedhexapeptideacleualahistyrasnlysamidemodelofhistoneh2b8085
AT sofferjonathan cuiiandniiiinteractionswiththeterminallyblockedhexapeptideacleualahistyrasnlysamidemodelofhistoneh2b8085
AT schweitzerstennerreinhard cuiiandniiiinteractionswiththeterminallyblockedhexapeptideacleualahistyrasnlysamidemodelofhistoneh2b8085
AT malandrinosgerasimos cuiiandniiiinteractionswiththeterminallyblockedhexapeptideacleualahistyrasnlysamidemodelofhistoneh2b8085
AT hadjiliadisnick cuiiandniiiinteractionswiththeterminallyblockedhexapeptideacleualahistyrasnlysamidemodelofhistoneh2b8085